CLINICAL INNOVATION ApS: Financial statements 2025
CVR: 29924880
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
CLINICAL INNOVATION ApS (CVR 29924880) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 2,775,826 and a net result of DKK 413,835 compared with DKK 95,746 the year before. That is an increase of 25.2% compared with the year before. Equity in the 2025 report amounted to DKK 3,821,950. The solvency ratio was 39.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 2,775,826
- Profit/Loss
- DKK 413,835
- Equity
- DKK 3,821,950
- Total Assets
- DKK 9,738,630
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 2.8M | 414K | 3.8M | 3 |
| 2024 | - | 2.2M | 96K | 3.8M | 2 |
| 2023 | - | 2.3M | -7K | 3.7M | 3 |
| 2022 | - | 3.4M | 41K | 3.7M | 8 |
| 2021 | - | 4M | 562K | 3.6M | 8 |
Official annual report
How creditworthy is CLINICAL INNOVATION ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
CLINICAL INNOVATION ApS has published its annual report for 2024. Gross profit came to DKK 2,216,934, and the net result was DKK 95,746.
About CLINICAL INNOVATION ApS
CLINICAL INNOVATION ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Claus Michael Dinesen. The board consists of Ole Hedemann (chair), Claus Michael Dinesen, Magnus Oliver Lundegård Pacheco Dinesen and Marc Phillip Gall Schultz Lorentzen. The company is owned by PIA & CLAUS DINESEN HOLDING ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 2,775,826 and a net result of DKK 413,835 compared with DKK 95,746 the year before. Equity in the 2025 report amounted to DKK 3,821,950.